da Chiara | Set 24, 2020 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of Mitral Regurgitation (MR), announced today the successful Firstin-Human implantation of its proprietary Saturn Transcatheter Mitral Valve along with...
da Chiara | Ago 7, 2020 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease, announced today the closing of a €20 million round of equity financing. Founded in 2015 by Giovanni Righini, a 30-year veteran of...
da Chiara | Ago 6, 2020 | Press release
InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation, announced today the appointment of veteran medical device executive J. Brent Ratz to the role of Chief Executive Officer of the...
da Chiara | Dic 5, 2019 | Press release
InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease, announces the appointment of experienced medical device entrepreneur, Mr. J. Brent Ratz, as non-executive independent...
da Chiara | Set 6, 2018 | Press release
Dr. Dawkins is transitioning from his position as a member of the InnovHeart Board which he joined in May of this year. Dr. Dawkins has more than 35 years experience as both a practicing phys ician and an executive within the medical device industry. He currently also...
da Chiara | Mag 7, 2018 | Press release
InnovHeart s.r.l., a developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease, announces the appointment of veteran medical device executive Keith D. Dawkins, M.D., to a newly created position on its Board of...
